About this event

EACR Congress 2026

Event type: Cancer research congress, oncology, translational science, drug development, diagnostics, laboratory innovation, academic research, biotech and pharmaceutical networking.

Estimated attendance: Typically a large international scientific audience, often several thousand delegates, with strong participation from academic researchers, biotech companies, pharma teams, diagnostics firms, laboratory technology providers, and clinical research stakeholders.

1) Who attends: Buyers / Attendees

EACR Congress is a highly specialized life sciences event. The attendee base is not a general business audience; it is a concentrated mix of scientific, commercial, and research decision-makers in oncology and related disciplines. This makes it especially valuable for attendee-list buyers looking for a premium audience with strong B2B and B2R (business-to-research) relevance.

Main attendee groups include:

• Cancer researchers and principal investigators
• Oncology scientists in academia, hospitals, and research institutes
• Translational medicine leaders
• Biotech founders and scientific directors
• Pharmaceutical R&D teams
• Clinical development and medical affairs professionals
• Diagnostic and biomarker specialists
• Laboratory technology and instrumentation buyers
• Immuno-oncology, cell therapy, and precision medicine specialists
• Postdoctoral researchers, doctoral students, and early-career scientists
• Conference exhibitors, sponsors, and scientific vendors

The best commercial buyers are usually not the students alone. The real value sits with research leaders, lab heads, biotech business development teams, pharma innovation teams, procurement stakeholders, and vendors serving the oncology ecosystem.

2) Where the show is happening + attendee geographic origin

Location: EACR Congress 2026 is an international congress held in Europe. The exact city and venue should be confirmed from the latest official event page before final list targeting.

Geographic origin of attendees: This is a truly international event with participation from across Europe, the United Kingdom, North America, Asia-Pacific, and selected global life sciences hubs. Attendance usually includes a strong European core, especially from countries with major cancer research clusters and biotech ecosystems.

Best geographic targeting:

• Western Europe: UK, Germany, France, Netherlands, Switzerland, Belgium, Spain, Italy, Sweden, Denmark
• Central and Eastern Europe: Poland, Czech Republic, Austria, Hungary, Slovenia, Portugal, Greece
• Global pharma and biotech hubs: USA, Canada, Singapore, Japan, South Korea, Israel
• Local host-city/regional universities, hospitals, and life sciences clusters

3) Audience reach

Reach type: Global with a strong European concentration.

This event has a high-value international reach because oncology research is inherently cross-border. The audience is highly specialized, highly educated, and strongly aligned with research tools, laboratory products, clinical development, scientific services, data platforms, and therapeutic innovation.

4) Sample buyer company names + websites

Below is a buyer-focused sample list designed for attendee-list research and lead targeting. These are companies and institutions that are highly relevant to cancer research, diagnostics, therapeutics, lab platforms, clinical trials, and oncology innovation.

Top 5 best samples to send client first: Roche, AstraZeneca, Novartis, Thermo Fisher Scientific, and Illumina. These cover pharma, translational oncology, lab tools, diagnostics, and genomics in one strong shortlist.

5) Job profiles, industries & event type

This congress should be approached as a scientific and commercial research environment. The best buyers are usually senior enough to influence budgets, partnerships, equipment selection, vendor evaluation, conference attendance, and research investments.

Best job profiles to target:

• Director of Oncology Research
• Head of Translational Medicine
• Scientific Affairs Director
• Clinical Development Manager
• Medical Science Liaison
• R&D Program Manager
• Biomarker Lead
• Precision Medicine Director
• Laboratory Manager
• Genomics Applications Manager
• External Innovation / Partnerships Lead
• Market Development Manager
• Product Marketing Manager, Life Sciences
• Chief Scientific Officer
• Principal Investigator
• Research Director
• Procurement / Lab Purchasing Manager
• Clinical Trial Operations Lead

Best industry filters to use from your provided industry list:

• Biotechnology
• Pharmaceuticals
• Medical Devices
• Hospital & Health Care
• Research
• Higher Education
• Health, Wellness & Fitness
• Information Technology & Services
• Computer Software
• Information Services
• Market Research
• Professional Training & Coaching
• Management Consulting
• Marketing & Advertising for scientific event sponsors and vendors

The event type is best classified as a highly targeted international scientific congress with a strong commercial layer for vendors, service providers, and life sciences solution companies.

6) Estimated attendance / expected footfall

Estimated attendance is generally in the several-thousand range, with a highly qualified audience. For oncology congresses of this scale, total footfall is usually strong but selective: the crowd is smaller than a mass trade show, yet the lead quality is significantly higher.

Typical footfall structure:

• Academic researchers and scientists: large share
• Pharma and biotech delegates: substantial and high value
• Exhibitors and sponsors: strong commercial presence
• Students and early-career researchers: meaningful supporting audience

Because this is a research congress, the number of qualified buyer contacts is more important than the raw number of attendees. For list sales, this event is strong when the target is scientific decision-makers, commercial life sciences buyers, and research procurement contacts.

7) Key focus areas & buyer engagement

Key focus areas likely include:

• Cancer biology and tumor microenvironment
• Immuno-oncology
• Precision medicine and biomarkers
• Genomics, proteomics, and multi-omics
• Translational research
• Drug discovery and preclinical development
• Clinical trials and trial design
• Diagnostics and companion diagnostics
• Single-cell analysis and advanced imaging
• Liquid biopsy and molecular profiling
• Cell therapy and targeted therapies
• Research collaborations and scientific partnerships

Best buyer engagement angles:

• Research tools and lab workflow solutions
• Clinical data platforms and bioinformatics
• Diagnostics and assay development
• Biopharma partnering and licensing
• Lab instrumentation and consumables
• Scientific recruiting and talent acquisition
• Conference sponsorship and brand visibility

If your client sells lab products, genomics platforms, oncology software, contract research services, or diagnostics, this event is especially attractive. If they sell broader consumer or generic B2B services, the fit becomes weaker unless there is a strong life sciences angle.

8) Client product fit note

Before finalizing the best buyers, please share your client website. I need to review the client product, target market, and value proposition so I can recommend the most relevant attendee categories and company targets for this specific event.

Why the website matters:

• If the client sells lab instruments, I will prioritize diagnostics, genomics, and research equipment buyers.
• If the client sells recruitment or data services, I will prioritize HR, partnerships, and research operations teams.
• If the client sells software, I will prioritize bioinformatics, clinical data, and research IT buyers.
• If the client sells pharma services, I will prioritize R&D, medical affairs, and business development leaders.

Once you share the website, I can refine the list to the exact buyer profile and produce a tighter, more profitable target list.

9) Final recommendation

EACR Congress 2026 is a strong event for attendee-list sales if your buyer is in oncology, life sciences, diagnostics, research tools, lab services, or pharmaceutical innovation. This is not a mass-market show, but it is a premium high-intent scientific audience with excellent commercial value.

Best buyer segments to collect:

• Oncology researchers and translational scientists
• Biotech and pharma R&D leaders
• Diagnostics and biomarker companies
• Lab technology and instrumentation vendors
• Clinical trial and CRO stakeholders
• Academic and hospital research decision-makers

Quality rating for B2B attendee-list sales: 9/10

Excellent fit for specialized life science and oncology targeting. The only caution is that the audience is technical and niche, so the offer must be aligned precisely to scientific, clinical, or commercial research needs.